Subscribe To
Beam Therapeutics to Participate in the 43rd Annual Cowen Healthcare Conference
CAMBRIDGE, Mass., March 01, 2023 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer, will participate in a panel titled, “Gene Editing Corporate Panel” during the 43rd Annual Cowen Healthcare Conference on Wednesday, March 8, 2023 at 10:30 […] The post Beam Therapeutics to Participate in the 43rd Annual Cowen Healthcare Conference appeared first on...
Read More
Posted: Mar 1 2023, 11:30
Author Name: forextv
Views: 110910